CX3CL1 and Alzheimer disease: However, studies to confirm a possible role for FKN in AD treatment are requested to be aligned as per the animals used, the protein fragment analyzed (soluble versus membrane-bound) and the concentrations used, considering that dose-dependent effects have been observed among the experiments.